Hepatitis-C Therapeutics

Developing "NS3/4A and NS5A" Dual-target Dual-drug Combination Therapy

Two-drug combination: the best treatment for the highly effective cure of all six hepatitis C subtypes of virus.

The advantage of combination of two targets not only improves the cure rate and shortens the course of treatment, but also eliminates the need for combination drugs with interferon, significantly reduces side effects and improves the quality of life of patients.